Centerbridge Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$2.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Genco Shipping & Trading
GNK
|
+$29.7M |
| 2 |
VTIQ
VectoIQ Acquisition Corp. II Class A Common Stock
VTIQ
|
+$19.1M |
| 3 |
Community Health Systems
CYH
|
+$3.52M |
| 4 |
AGCB
Altimeter Growth Corp 2
AGCB
|
+$1.48M |
| 5 |
Alpha Tau Medical Warrant
DRTSW
|
+$24K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 20.81% |
| 2 | Consumer Discretionary | 16.13% |
| 3 | Industrials | 3.86% |
| 4 | Financials | 1.65% |
| 5 | Technology | 0.69% |
Similar funds
Centerbridge Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Centerbridge Partners held 37 positions worth $875M, down 23% from $1.13B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Centerbridge Partners withdrew a net $66.2M in Q3 2022, closing 4 positions and reducing 1 holding. Its most notable exit was VectoIQ Acquisition Corp. II Class A Common Stock, an estimated $19.1M position sold in full.
By sector, the portfolio is most concentrated in Real Estate at 21% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Centerbridge Partners opened a new position in Bausch Health worth $2.93M.
- Centerbridge Partners's largest Q3 2022 buy was Bausch Health: 425,000 shares worth $2.93M.
- Centerbridge Partners's biggest Q3 2022 reduction was Genco Shipping & Trading, cutting an estimated $29.7M.
- Centerbridge Partners fully exited VectoIQ Acquisition Corp. II Class A Common Stock in Q3 2022, selling an estimated $19.1M.
- Centerbridge Partners's ten largest holdings make up 100% of its $875M portfolio in Q3 2022.
- Centerbridge Partners opened 1 new position and closed 4 in Q3 2022.
- Centerbridge Partners's portfolio value fell 23% quarter-over-quarter to $875M.
Based on Centerbridge Partners's 13F filing for Q3 2022, filed 14 Nov 2022.